From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

Author(s)
Christian Hartinger, Stefanie Zorbas-Seifried, Michael Jakupec, Haralabos Zorbas, Bernhard Keppler
Organisation(s)
Department of Inorganic Chemistry
External organisation(s)
Max-Planck-Institut für Chemie (Otto-Hahn-Institut), Ludwig-Maximilians-Universität München
Journal
Journal of Inorganic Biochemistry
Volume
100
Pages
894-904
No. of pages
11
ISSN
0162-0134
Publication date
2006
Peer reviewed
Yes
Austrian Fields of Science 2012
104003 Inorganic chemistry
Portal url
https://ucrisportal.univie.ac.at/en/publications/1dd7be03-9df5-4ca8-96d2-3c5e08d06b05